10月6日，浙江同源康医药股份有限公司（股票代码：02410，股票名称：同源康医药-B）披露截至2026年9月30日止的证券变动月报表。公告显示，公司于本报告期内注册股本总额为人民币380,065,818元（每股面值人民币1元），与上月相比无新增或减少，未发生购回、注销或库藏股的相关活动。
报告期内，公司已发行普通股（H股）总数为380,065,818股，与上月持平；库存股数量保持在零。公司确认已符合最低公众持股量要求，未出现违反香港联交所《上市规则》相关规定的情况。同时，当月未有新的股份期权或股权激励计划变动，也未有可转债或其他协议安排的情况披露。
截至9月底，公司整体股本无变化，维持在380,065,818股注册资本。公司表示将继续遵守香港联交所《上市规则》及相关法律法规。公告由执行董事、董事长兼总裁吴豫生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.